{'Year': '2016'}
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
Interindividual variability of pharmacogenetics may account for unpredictable neurotoxicities of taxanes.